Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine

Invest Radiol. 2006 Mar;41(3):299-304. doi: 10.1097/01.rli.0000188362.12555.62.

Abstract

Objective: The aim of this study was to determine whether gadofluorine, a paramagnetic magnetic resonance imaging (MRI) contrast agent, selectively enhances carotid atherosclerotic plaques in Yucatan miniswine.

Methods: Atherosclerotic plaques were induced in the left carotid arteries (LCA) of Yucatan miniswine (n=3) by balloon denudation and high cholesterol diet. T1-weighted MRI was performed before and 24 hours after gadofluorine injection (at a dose of 100 micromol/kg) to assess the enhancement of the balloon-injured LCA wall relative to healthy, uninjured right carotid artery (RCA) wall. Histopathology was performed to verify the presence and composition of the atherosclerotic plaques imaged with MRI.

Results: Gadofluorine was found to enhance LCA atherosclerotic lesions relative to RCA wall by 21% (P<0.025) 24 hours after contrast injection. Enhancement of healthy LCA wall relative to healthy RCA wall was not observed.

Conclusion: Gadofluorine selectively enhances carotid atherosclerotic plaques in Yucatan miniswine. Gadofluorine appears to be a promising MR contrast agent for detection of atherosclerotic plaques in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteriosclerosis / pathology*
  • Carotid Artery Diseases / pathology*
  • Contrast Media* / pharmacokinetics
  • Magnetic Resonance Imaging / methods*
  • Organometallic Compounds* / pharmacokinetics
  • Swine
  • Swine, Miniature

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadofluorine